Valerie Wojna to HIV Infections
This is a "connection" page, showing publications Valerie Wojna has written about HIV Infections.
Connection Strength
1.723
-
Wojna V. Neuroinflammation and HIV-Associated Cognitive Impairment: Can They Be Eradicated? Neurology. 2022 09 20; 99(12):499-500.
Score: 0.333
-
Ram?rez-Marrero FA, P?rez-Frontera S, Amalbert-Birriel MA, Matos M, Santana-Bagur J, Frontera WR, Wojna V. Brief Report: Effects of Low-Volume High-Intensity Interval Training in Hispanic HIV+ Women: A Nonrandomized Study. J Acquir Immune Defic Syndr. 2020 07 01; 84(3):285-289.
Score: 0.288
-
Agsalda-Garcia M, Shiramizu B, Melendez L, Plaud M, Liang CY, Wojna V. Different levels of HIV DNA copy numbers in cerebrospinal fluid cellular subsets. J Health Care Poor Underserved. 2013 Nov; 24(4 Suppl):8-16.
Score: 0.181
-
Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis. 2013 Apr; 56(7):1004-17.
Score: 0.170
-
Gerena Y, Skolasky RL, Velez JM, Toro-Nieves D, Mayo R, Nath A, Wojna V. Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women. PLoS One. 2012; 7(5):e37358.
Score: 0.164
-
Wojna V, Robles L, Skolasky RL, Mayo R, Selnes O, de la Torre T, Maldonado E, Nath A, Mel?ndez LM, Lasalde-Dominicci J. Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women. J Neurovirol. 2007 Dec; 13(6):561-8.
Score: 0.120
-
Wojna V, Skolasky RL, Hechavarr?a R, Mayo R, Selnes O, McArthur JC, Mel?ndez LM, Maldonado E, Zorrilla CD, Garc?a H, Kraiselburd E, Nath A. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol. 2006 Oct; 12(5):356-64.
Score: 0.111
-
Shikuma CM, Wojna V, De Gruttola V, Siriwardhana C, Souza SA, Rodriguez-Benitez RJ, Turner EH, Kallianpur K, Bolzenius J, Chow D, Matos M, Shiramizu B, Clements DM, Premeaux TA, Ndhlovu LC, Paul R. Impact of antiretroviral therapy intensification with C-C motif chemokine receptor 5 antagonist maraviroc on HIV-associated neurocognitive impairment. AIDS. 2023 11 01; 37(13):1987-1995.
Score: 0.089
-
Cantres-Rosario YM, Acevedo-Mariani FM, P?rez-Laspiur J, Haskins WE, Plaud M, Cantres-Rosario YM, Skolasky R, M?ndez-Berm?dez I, Wojna V, Mel?ndez LM. Microwave & magnetic proteomics of macrophages from patients with HIV-associated cognitive impairment. PLoS One. 2017; 12(7):e0181779.
Score: 0.059
-
Jimenez-Torres GJ, Wojna V, Rosario E, Hechevarr?a R, Alem?n-Batista AM, Matos MR, Madan A, Skolasky RL, Acevedo SF. Assessing health-related resiliency in HIV+ Latin women: Preliminary psychometric findings. PLoS One. 2017; 12(7):e0181253.
Score: 0.059
-
Bandaru VV, Mielke MM, Sacktor N, McArthur JC, Grant I, Letendre S, Chang L, Wojna V, Pardo C, Calabresi P, Munsaka S, Haughey NJ. A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology. 2013 Oct 22; 81(17):1492-9.
Score: 0.045
-
Morales D, Hechavarria R, Wojna V, Acevedo SF. YWHAE/14-3-3e: a potential novel genetic risk factor and CSF biomarker for HIV neurocognitive impairment. J Neurovirol. 2013 Oct; 19(5):471-8.
Score: 0.045
-
Laspiur JP, Anderson ER, Ciborowski P, Wojna V, Rozek W, Duan F, Mayo R, Rodr?guez E, Plaud-Valent?n M, Rodr?guez-Orengo J, Gendelman HE, Mel?ndez LM. CSF proteomic fingerprints for HIV-associated cognitive impairment. J Neuroimmunol. 2007 Dec; 192(1-2):157-70.
Score: 0.030
-
Rozek W, Ricardo-Dukelow M, Holloway S, Gendelman HE, Wojna V, Melendez LM, Ciborowski P. Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. J Proteome Res. 2007 Nov; 6(11):4189-99.
Score: 0.030